NeuroOne Medical Technologies
NeuroOne Medical Technologies
NMTC
NASDAQ
1.01
USD
6.32%
About
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders.
It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products..
Financials Amount (in millions)
Income statement
Balance sheet
Cash flow
Ratios
| Price and Volume | |
|---|---|
| Volume | |
| Ten Day Average Volume | 41.7K |
| Three Month Average Volume | 1.8M |
| High Low | |
| Fifty-Two Week High | 2 USD |
| Fifty-Two Week Low | 0.602 USD |
| Fifty-Two Week High Date | 08 Dec 2023 |
| Fifty-Two Week Low Date | 05 Aug 2024 |
| Price and Volume | |
| Current Price | 0.7964 USD |
| Beta | 1 |
| Relative Price Change | |
| Four Week Relative Price Change | 13.87% |
| Thirteen Week Relative Price Change | -19.98% |
| Twenty-Six Week Relative Price Change | -40.63% |
| Fifty-Two Week Relative Price Change | -25.27% |
| Year-to-Date Relative Price Change | -57.44% |
| Price Change | |
| One Day Price Change | -1.58% |
| Thirteen Week Price Change | -14.36% |
| Twenty-Six Week Price Change | -34.72% |
| Five Day Price Change | 1.62% |
| Fifty-Two Week Price Change | -6.36% |
| Year-to-Date Price Change | -49.59% |
| Month-to-Date Price Change | 6.19% |
| Per Share Data | |
|---|---|
| Book Value | |
| Book Value Per Share (Last Fiscal Year) | 0.26116 USD |
| Book Value Per Share (Most Recent Quarter) | 0.10815 USD |
| Tangible Book Value Per Share (Last Fiscal Year) | 0.25742 USD |
| Tangible Book Value Per Share (Most Recent Quarter) | 0.10554 USD |
| EBITD | |
| EBITD Per Share (Trailing Twelve Months) | -0.48192 USD |
| Revenue | |
| Revenue Per Share (Last Fiscal Year) | 0.1903 USD |
| Revenue Per Share (Trailing Twelve Months) | 0.15929 USD |
| Dividend | |
| Dividend Per Share (Last Fiscal Year) | -99999.99 USD |
| Dividend Per Share (Trailing Twelve Months) | 0 USD |
| Dividend Per Share (5 Year) | -99999.99 USD |
| Earnings Per Share | |
| Excluding Extraordinary Items (Last Fiscal Year) | -0.65446 USD |
| Excluding Extraordinary Items (Trailing Twelve Months) | -0.49159 USD |
| Normalized (Last Fiscal Year) | -0.65446 USD |
| Basic Excluding Extraordinary Items (Last Fiscal Year) | -0.65446 USD |
| Basic Excluding Extraordinary Items (Trailing Twelve Months) | -0.49159 USD |
| Including Extraordinary Items (Last Fiscal Year) | -0.65446 USD |
| Including Extraordinary Items (Trailing Twelve Months) | -0.49159 USD |
| Cash | |
| Cash Per Share (Last Fiscal Year) | 0.22243 USD |
| Cash Per Share (Most Recent Quarter) | 0.05817 USD |
| Cash Flow Per Share (Last Fiscal Year) | -0.64348 USD |
| Cash Flow Per Share (Trailing Twelve Months) | -0.47659 USD |
| Free Cash Flow Per Share (Trailing Twelve Months) | -0.45774 USD |
| Margins | |
|---|---|
| Cash Flow Revenue | |
| Cash Flow Revenue (5 Year) | -501 |
| Cash Flow Revenue (Trailing Twelve Months) | -287 |
| Pretax Margin | |
| Pretax Margin (Trailing Twelve Months) | -305.37% |
| Pretax Margin (Last Fiscal Year) | -343.92% |
| Pretax Margin (5 Year) | -674.97% |
| Gross Margin | |
| Gross Margin (Last Fiscal Year) | 56.62% |
| Gross Margin (Trailing Twelve Months) | 29.60% |
| Gross Margin (5 Year) | -99,999.99% |
| Operating Margin | |
| Operating Margin (Last Fiscal Year) | -346.69% |
| Operating Margin (Trailing Twelve Months) | -308.72% |
| Operating Margin (5 Year) | -587.90% |
| Net Profit Margin | |
| Net Profit Margin (Last Fiscal Year) | -343.92% |
| Net Profit Margin (Trailing Twelve Months) | -305.37% |
| Net Profit Margin (5 Year) | -674.97% |
| Growth | |
|---|---|
| Book Value | |
| Book Value Per Share (5 Year) | -99,999.99% |
| Tangible Book Value (5 Year) | -99,999.99% |
| Free Operating Cash Flow | |
| Free Operating Cash Flow (5 Year) | -99,999.99% |
| Revenue | |
| Revenue Change MRQ vs 1 Year Ago | 31.09% |
| Revenue Growth (3 Year) | -99,999.99% |
| Revenue Change (Trailing Twelve Months) | -15.26% |
| Revenue Per Share Growth | -99,999.99% |
| Revenue Growth (5 Year) | 21.42% |
| Capital Spending Debt | |
| Capital Spending (5 Year) | -99,999.99% |
| Total Debt (5 Year) | -99,999.99% |
| Dividends | |
| Dividend Growth (3 Year) | -99,999.99% |
| Earnings Per Share | |
| EPS Change MRQ vs 1 Year Ago | 48.73% |
| EPS Change (Trailing Twelve Months) | 18.54% |
| EPS Growth (3 Year) | -99,999.99% |
| EPS Growth (5 Year) | -99,999.99% |
| EBITDA | |
| EBITDA (5 Year) | -99,999.99% |
| EBITDA (5 Year Interim) | -99,999.99% |
| Net Profit Margin | |
| Net Profit Margin Growth (5 Year) | -99,999.99% |
| Valuation | |
|---|---|
| Total Price to Book | |
| Price to Tangible Book (Last Fiscal Year) | 4 |
| Price to Tangible Book (Most Recent Quarter) | 8 |
| Price to Free Cash Flow | |
| Price to Free Cash Per Share (Last Fiscal Year) | -100,000 |
| Price to Free Cash Per Share (Trailing Twelve Months) | -100,000 |
| Net Debt | |
| Net Debt (Most Recent Quarter) | -1,619,980 |
| Net Debt (Last Fiscal Year) | -5,322,490 |
| Price to Sales | |
| Price to Sales (Last Fiscal Year) | 7 |
| Price to Sales (Trailing Twelve Months) | 6 |
| Price to Earnings | |
| PE Excluding Extraordinary Items (Last Fiscal Year) | -100,000 |
| PE Normalized (Last Fiscal Year) | -100,000 |
| PE Basic Excluding Extraordinary Items (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items High (Trailing Twelve Months) | -100,000 |
| PE Excluding Extraordinary Items Low (Trailing Twelve Months) | -100,000 |
| PE Including Extraordinary Items (Trailing Twelve Months) | -100,000 |
| Dividends | |
| Dividend Yield (5 Year) | -99,999.99% |
| Dividend Yield | -99,999.99% |
| Current Dividend Yield | 0.00% |
| Price to Book | |
| Price to Book (Last Fiscal Year) | 3 |
| Price to Book (Most Recent Quarter) | 7 |
| Financial Strength | |
|---|---|
| Debt to Equity | |
| Long Term Debt to Equity (Last Fiscal Year) | 0 |
| Long Term Debt to Equity (Most Recent Quarter) | 0 |
| Payout Ratio | |
| Payout Ratio (Last Fiscal Year) | -99,999.99% |
| Payout Ratio (Trailing Twelve Months) | -99,999.99% |
| Quick Ratio | |
| Quick Ratio (Last Fiscal Year) | 3 |
| Quick Ratio (Most Recent Quarter) | 1 |
| Enterprise Value | |
| Current Enterprise Value to Free Cash Flow (Last Fiscal Year) | -100,000 |
| Current Enterprise Value to Free Cash Flow (Trailing Twelve Months) | -100,000 |
| Current Ratio | |
| Current Ratio (Last Fiscal Year) | 4 |
| Current Ratio (Most Recent Quarter) | 2 |
| Free Cash Flow | |
| Free Cash Flow (Last Fiscal Year) | -13,270,990 |
| Free Cash Flow (Trailing Twelve Months) | -11,388,690 |
| Net Interest Coverage | |
| Net Interest Coverage (Last Fiscal Year) | -100,000 |
| Net Interest Coverage (Trailing Twelve Months) | -100,000 |
| Total Debt to Equity | |
| Total Debt to Equity (Last Fiscal Year) | 0 |
| Total Debt to Equity (Most Recent Quarter) | 0 |
| Management Effectiveness | |
|---|---|
| Return on Assets | |
| Return on Assets (Last Fiscal Year) | -113.38% |
| Return on Assets (Trailing Twelve Months) | -226.84% |
| Return on Assets (5 Year) | -172.88% |
| Return on Equity | |
| Return on Equity (Last Fiscal Year) | -149.61% |
| Return on Equity (Trailing Twelve Months) | -349.13% |
| Return on Equity (5 Year) | -291.56% |
| Return on Investment | |
| Return on Investment (Last Fiscal Year) | -147.98% |
| Return on Investment (Trailing Twelve Months) | -334.70% |
| Return on Investment (5 Year) | -274.74% |